Cannabis Testing Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product, Test Type and End User : Global Opportunity Analysis and Industry Forecast, 2019-2027

Cannabis Testing Market Overview:

The global cannabis testing market was valued at $1,029 million in 2019, and is projected to reach $2,445 million by 2027, registering a CAGR of 11.9%.

Cannabis testing refers to the analysis that an individual sample of cannabis may be examined to determine THC, CBD, and terpene levels as well as for contaminants and impurities such as residual solvents, mold, disease, pests or pesticide residue. Each individual state and municipality can impose its own standards and regulations for what needs to be tested and printed on cannabis labels. Furthermore, individual growers may opt for more stringent standards and go as far as to have their samples tested for CBC and CBG levels. This testing can be performed only by certified chemists and lab technicians. Previously, both cultivation and sales of cannabis were ban across the globe for several years. Now, many countries are recognizing the benefits of cannabis for medicinal purposes and rescinding their ban.

The sudden outbreak of the COVID-19 pandemic has a positive and a negative impact on the pharmaceutical and life sciences industry. Certain market segments have been more severely affected due to the low demand for instruments, consumables, and reagents as well as due to supply chain disruptions and trade restrictions. Overall, labs across the globe were shut down or running at a reduced capacity. The labs, which were fully or partially open were working majorly on COVID-19 testing instead of carrying out usual operations. The medical cannabis market lost some revenue due to factors such as testing laboratories closures, disrupted supply chains, general economic slowdown, and restricted movement. In addition, numerous market players providing products and software to the cannabis testing industry witnessed a decline in the sales of instruments and consumables due to the shutdown of labs, declining number of cannabis tests performed, and certain restrictions on the import and export of cannabis testing products. These factors have led to a decline in the sales of consumables & instruments used in the cannabis testing industry, thereby hampering the growth of the cannabis testing market. This was majorly due to the decline in the purchase of the products, subsequently impacting the growth of the products & consumables segment of the cannabis testing industry. 

Surge in demand for cannabis legalization in several countries for medical purposes and increase in adoption of LIMS in cannabis testing laboratories are the key factors driving the growth of the cannabis testing market. Furthermore, collaborations between major companies are also expected to boost the market growth. However, high startup cost for cannabis testing laboratories constitute is expected to restrain the growth of the market. These laboratories have to make significant investments in procuring and maintaining high-priced, advanced analytical equipment. Conversely, emerging economies across developing regions, such as LATAM and Asia-Pacific, are expected to provide new opportunities for cannabis testing market players in future.

The global cannabis testing market is segmented on the basis of product, test type, end user, and region. On the basis of product, the cannabis testing services market is classified into instruments, consumables, and software. Instruments segment is further classified into chromatography instruments and spectroscopy instruments. Furthermore, chromatography instruments segment is subdivided into liquid chromatography and gas chromatography. Spectroscopy instruments segment is bifurcated into mass spectrometry instruments and atomic spectroscopy instruments. By test type, it is categorized into heavy metal testing, microbial analysis, potency testing, residual screening, and others. By end user, it is divided into cannabis cultivators/growers, cannabis drug manufacturers, and others.

Segmental review

By products, the instruments segment is anticipated to grow with the fastest rate over the forecast period. This is attributed to increasing investments by the major players in the development of technologically advanced instruments. This is a major factor, which fuels the growth of this segment. On the other side, the consumables segment is the largest contributing segment in the global cannabis testing market, owing to frequent use of consumables for cannabis testing.

North America accounted for the largest share of revenue in 2019, and is anticipated to maintain its dominance from 2020 to 2027, owing to legalization of cannabis (especially in the U.S.) and the growing ease of availability of instruments, software, and services for cannabis testing. However, LAMEA is expected to grow at the highest CAGR, owing to increasing number of cannabis cultivators, testing laboratories, and legalization of cannabis for medical use. 

Some of the key players operating in the cannabis testing market include Agilent Technologies Inc., Danaher Corporation, Merck KGAA, PerkinElmer, Restek Corporation, SC Laboratories, Shimadzu Corporation, Steep Hill, Thermo Fisher Scientific, and Waters Corporation.

Key Benefits For Stakeholders

• This report entails a detailed quantitative analysis along with the current global cannabis testing market trends from 2020 to 2027 to identify the prevailing opportunities along with the strategic assessment.
• The cannabis testing market forecast is studied from 2020 to 2027.
• The cannabis testing market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global cannabis testing market.
• Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global cannabis testing market.

Key Market Segments

By Product

• Instruments
  • Chromatography instruments        
    • Liquid chromatography    
    • Gas chromatography    
  • Spectroscopy instruments        
    • Mass spectrometry instruments    
    • Atomic spectroscopy instruments    
• Consumables
• Software

By Test Type

• Heavy metal testing
• Microbial analysis
• Potency testing
• Residual screening
• Others
• End User
• Cannabis cultivators/growers
• Cannabis drug manufacturers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Rest of Europe
• Asia-Pacific
  • Australia
  • Japan
  • China
  • Rest of Asia-Pacific
• LAMEA
  • Latin America
  • Middle East and Africa

  Cannabis Testing Market Report Highlights

Aspects	Details
By PRODUCT	Instruments Chromatography instruments Liquid chromatography Gas chromatography Spectroscopy instruments Mass spectrometry instruments Atomic spectroscopy instruments Consumables Software
By TEST TYPE	Heavy metal testing .Microbial analysis Potency testing Residual screening Others
By END USER	Cannabis cultivators/growers Cannabis drug manufacturers Others
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Thermo Fisher Scientific Inc., Shimadzu Coporation, MERCK KGAA, Steep Hill, .Danaher Corporation, Restek Corporation, Perkin Elmer, Agilent Technologies Inc., SC Laboratories, Water Corporation

Analyst Review

Cannabis legalization in several countries for medical purposes and increase in adoption of Laboratory Information Management Systems (LIMS) in cannabis testing laboratories are the key factors driving the growth of the cannabis testing market. Furthermore, collaborations between major companies are also expected to boost the market growth. 

North America accounted for the highest market share in 2019 due to the established biopharmaceutical industry and the presence of major players operating in the cannabis testing market in North America, followed by Europe and Asia-Pacific. LAMEA is expected to exhibit the fastest market growth due to the growing biopharmaceutical industry, increasing life science research, rising investments by pharmaceutical and biotechnology companies, and growing number of cannabis testing laboratories in the region coupled with the legalization of cannabis for medical use. These factors are anticipated to drive the market growth.

Author Name(s) : Sayali Shinde| Smita Nerkar | Roshan Deshmukh

Related Tags

• Drug Discovery
• Neurological Disorders
• Neurology